Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
francesco.marampon@uniroma1.it
Francesco Marampon
Professore Associato
Struttura:
DIPARTIMENTO DI SCIENZE RADIOLOGICHE, ONCOLOGICHE E ANATOMO-PATOLOGICHE
E-mail:
francesco.marampon@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2023
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
2023
Clinical efficacy of adjuvant radiotherapy for WHO grade II intracranial meningioma
WORLD NEUROSURGERY
2023
Abscopal Effect on Bone Metastases from Solid Tumors: A Systematic Review and Retrospective Analysis of Challenge within a Challenge
BIOMEDICINES
2023
Radio-guided lung surgery: a feasible approach for a cancer precision medicine
DIAGNOSTICS
2023
Extraosseous distribution of 99mTc-diphosphonates during bone scintigraphy: review of the literature with case series presentation
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
2023
Anti-proliferative, pro-apototic and anti-migratory properties of HDAC inhibitor PXD-101 on osteosarcoma cell lines
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
2023
ATX-101, a peptide targeting PCNA, has antitumor efficacy alone or in combination with radiotherapy in murine models of human glioblastoma
CANCERS
2022
The botanical drug PBI-05204, a supercritical CO2 extract of nerium oleander, is synergistic with radiotherapy in models of human glioblastoma
FRONTIERS IN PHARMACOLOGY
2022
MET inhibition sensitizes rhabdomyosarcoma cells to NOTCH signaling suppression
FRONTIERS IN ONCOLOGY
2022
Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma
ONCOLOGY REPORTS
2022
Abstract 6307: The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, augments the antitumor efficacy of radiotherapy in treatment of human glioblastoma
CANCER RESEARCH
2022
Radioresistance in rhabdomyosarcomas: much more than a question of dose
FRONTIERS IN ONCOLOGY
2022
Translational implications for radiosensitizing strategies in rhabdomyosarcoma
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2022
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo
FRONTIERS IN PHARMACOLOGY
2022
Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications
CANCERS
2022
Safety and efficacy of combining afatinib and whole-brain radiation therapy in treating brain metastases from EGFR-mutated NSCLC: a case report and literature review
BJR CASE REPORTS
2022
The prostacyclin analogue Iloprost modulates CXCL10 in systemic sclerosis
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2022
Phosphodiesterase type-5 inhibitor tadalafil modulates steroid hormones signaling in a prostate cancer cell line
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2021
MiR-200c-3p contrasts PD-L1 induction by combinatorial therapies and slows proliferation of epithelial ovarian cancer through downregulation of β-Catenin and c-Myc
CELLS
2021
1
2
3
4
5
seguente ›
ultima »
Progetti di Ricerca
Coding and non-coding genes driving radio-resistance mechanisms in rhabdomyosarcoma tumors: cues to new biomarkers and therapeutic targets.
Identifying and targeting pathways involved in radio-resistance in pediatric rhabdomyosarcoma
HDACs inhibitors as radiosensitizers for rhabdomyocarcoma cancer therapy
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma